Sh Vaccine Center – The New Indian Express

Through PTI

NEW DELHI: More than 1.82 crore of COVID-19 vaccine doses are available with states and union territories, and more than 4 lakh will be received by them in the next three days, the ministry of Union Health.

So far, the central government has provided, through the toll-free category and the direct state procurement category, over 22.77 crore of vaccine doses to states and UTs.

Of these, the total consumption, including waste, is 20,80,09,397 doses, according to data available at 8 a.m. on Saturday, the ministry said.

“More than 1.82 crore (1,822.21,403) doses of COVID-19 vaccine are still available with States and TUs to administer. Additionally, 4,86180 doses of vaccine are being prepared and will be received by States and UTs within the next 3 days, ”the department said.

As part of the national vaccination campaign, the Center supported states and UTs by providing them with free Covid vaccines.

In addition, it facilitated the direct purchase of vaccines by states and UTs.

Vaccination is an integral pillar of the Union government’s comprehensive strategy for containment and management of the pandemic, as well as testing, monitoring, treatment and appropriate behavior for Covid, the ministry said.

READ ALSO | Odisha extends deadline for global tender for purchase of Covid vaccine until June 4

The implementation of the liberalized and accelerated phase 3 strategy of the Covid vaccination began from May 1, he said.

Under this strategy, 50% of the vaccine doses authorized by the Central Medicines Laboratory (CDL) of any manufacturer would be purchased each month by the Indian government.

It would continue to make these doses available to states for free, as it did before, the ministry said.

The vaccine, being a biological product, takes time for harvesting and quality testing and it cannot be done overnight to ensure a safe product, the Union Health Ministry said on Friday.

The ministry said the Indian government, through the National Group of Experts on the Administration of COVID-19 Vaccines (NEGVAC), regularly interacts with domestic and international manufacturers such as Pfizer, Moderna to make the vaccines available in the country.

“The concrete actions are a stark indication that the Indian government is doing everything possible to increase vaccine production in the country and to attract foreign vaccine manufacturers to provide the vaccine doses required for the national immunization program. Covid, “the ministry said in a statement.

Despite availability constraints, India has done well in covering 200 million people in just 130 days, which is the third largest coverage in the world, the ministry said.

The Indian government has been supporting the efforts of states and UTs for effective management of patients with Covid in the context of vaccination under the ‘whole of government’ approach since January of this year.

With Covid being a pandemic with a global impact, there has been a strong global demand for vaccines with a limited number of manufacturers and limited manufacturing capacity in countries.

India has a population of 1.4 billion, which is a substantial share of the world’s population, the statement said.

In India, two vaccines were approved by the regulatory body in January.

The two manufacturers, Serum Institute and Bharat Biotech, had the capacity to deliver around 1 crore in doses as of December 2020.

READ ALSO | Delhi launches global tender to purchase 1 crore of doses of Covid vaccine

NEGVAC was established in August 2020 to provide advice on all aspects of vaccine introduction, including prioritization of beneficiaries, procurement, vaccine selection and delivery.

Priority of beneficiaries of COVID-19 vaccination in India was established based on review of available scientific evidence, WHO proposed guidelines, global examples and practices followed in other countries with the primary purpose of protecting healthcare and frontline workers.

As a result, the in-country vaccination campaign was sequentially extended to cover priority groups starting with health workers (HCs) on January 16, followed by frontline workers (field workers) from February 2. , people aged 60 and over and those aged 45. 59 years of co-morbidities were covered from March 1.

Thereafter, from April 1, anyone aged 45 and over is eligible for vaccination.

Such an approach has yielded positive results, achieving more than 90% first-dose coverage among registered healthcare workers and around 84% first-dose coverage among registered field workers, the statement said.

A “liberalized pricing and accelerated national COVID-19 vaccination strategy” was adopted on May 1, which guides the current phase of the vaccination campaign.

This strategy aims to encourage manufacturers to speed up vaccine production and attract new manufacturers.

This will increase vaccine production, resulting in greater vaccine availability with flexibility in pricing and purchasing, the statement said.

“The manufacturing capacities have been increased. Since the vaccine is a biological product, it takes time for harvesting and quality testing. It cannot be done overnight to ensure a safe product. of manufacturing capacity must also be a guided process, “said statement.

Russian Sputnik V is the third vaccine to gain approval from the Comptroller General of Medicines of India (DCGI) for restricted use in emergencies and is being used in a few private hospitals.

These are expected to increase over the next few days.

Meanwhile, the cumulative number of COVID-19 vaccine doses administered in the country has exceeded 20.86 crore, the Union Health Ministry said on Friday.

He said 13,36,309 people aged 18 to 44 received their first dose and 275 beneficiaries in the same group received their second dose of COVID vaccine on Friday.

A total of 1,66.47,122 beneficiaries in this age group have been vaccinated since the start of phase three of the vaccination campaign.

Bihar, Gujarat, Madhya Pradesh, Rajasthan and Uttar Pradesh administered the first dose of coronavirus vaccine to more than 10 lakh beneficiaries in the 18-44 age group.

The cumulative number of COVID-19 vaccine doses administered in the country stood at 20.86.12,834, according to a 19-hour interim report.

This includes 98,44,619 healthcare workers and 1,54,41,200 frontline workers who received the first dose, 67,58,839 healthcare workers and 84,47,103 frontline workers who took both doses.

In addition, 1,66.47,122 beneficiaries in the 18-44 age group received the first dose and 275 people in the same group received both injections.

In addition to 6,44,71,232 and 1,03,37,925 beneficiaries aged between 45 and 60 received the first and second dose respectively.

READ ALSO | Indian Immunologicals Limited of Hyderabad to supply raw material for vaccine to Bharat Biotech

In addition, 5,81,23,297 elderly people and 1,85,41,222 of these beneficiaries received the first and second doses, respectively.

As on day 133 of the vaccination campaign, 28,074,411 doses were administered, of which 25,99,754 beneficiaries received the first dose and 2.07,657 the second dose, according to the interim report, the ministry said adding the reports. end of the day. would be finished late at night.

The vaccination exercise as a tool to protect the country’s most vulnerable population groups against COVID-19 continues to be regularly reviewed and monitored at the highest level, the health ministry said.

Source link

About Thomas Brown

Check Also

Daily COVID-19 Data Still Important | News, Sports, Jobs

America continues to open up after the frightening and tragic months of the COVID-19 pandemic, …

Leave a Reply

Your email address will not be published. Required fields are marked *